US Stock MarketDetailed Quotes

JAGX Jaguar Health

Watchlist

1.0500
-0.0100-0.94%

Close Oct 31 16:00 ET

1.0800
+0.0300+2.86%

Post 18:34 ET

9.70MMarket Cap-230P/E (TTM)

Jaguar Health Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

9.78%-8.17M

29.14%-7.05M

-0.42%-33.24M

-16.00%-7.45M

20.39%-6.79M

13.40%-9.06M

-29.24%-9.95M

5.34%-33.1M

28.02%-6.42M

9.57%-8.53M

Net income from continuing operations

19.71%-9.72M

27.54%-9.15M

14.68%-41.87M

-2.63%-9.15M

36.66%-7.99M

-28.95%-12.11M

30.47%-12.63M

6.70%-49.08M

37.76%-8.91M

-3.42%-12.61M

Operating gains losses

400.00%30K

-4,064.52%-1.23M

-266.71%-3.65M

1,000.00%9K

-369,300.00%-3.69M

100.96%6K

-98.90%31K

-10.22%2.19M

---1K

--1K

Depreciation and amortization

-9.98%559K

10.71%610K

4.19%2.39M

-1.83%591K

6.47%625K

-4.17%621K

21.10%551K

26.42%2.29M

25.94%602K

24.10%587K

Other non cash items

-99.71%9K

-81.00%274K

6.33%13.38M

-45.31%1.72M

124.06%7.09M

10.36%3.13M

-58.12%1.44M

142.55%12.58M

103.90%3.14M

159.69%3.16M

Change In working capital

37.91%-1.24M

14.53%-153K

-150.65%-11.1M

-43.51%-3.33M

-2,221.58%-5.6M

53.86%-2M

-107.28%-179K

-295.32%-4.43M

-220.59%-2.32M

63.54%-241K

-Change in receivables

411.61%349K

-54.85%465K

170.78%298K

-1,145.16%-324K

28.16%-296K

-168.71%-112K

607.39%1.03M

-117.43%-421K

-49.18%31K

-120.92%-412K

-Change in inventory

-227.62%-536K

110.18%169K

-1.93%-2.17M

-91.49%-810K

-179.86%-115K

122.50%420K

-7,645.45%-1.66M

-0.28%-2.12M

-9.30%-423K

112.96%144K

-Change in prepaid assets

57.86%-1.53M

-610.00%-1.14M

-221.22%-5.01M

-668.81%-2.39M

2,079.66%1.17M

-113.79%-3.63M

-131.56%-160K

-95.98%-1.56M

-154.28%-311K

44.34%-59K

-Change in payables and accrued expense

-56.48%628K

-265.54%-1.13M

-802.95%-3.81M

112.22%288K

-2,475.19%-6.22M

207.68%1.44M

-68.54%682K

-83.02%542K

-208.32%-2.36M

118.32%262K

-Change in other current assets

-50.00%1K

4,183.33%735K

96.91%-17K

-99.64%3K

95.51%-4K

100.15%2K

-260.00%-18K

-34.80%-550K

289.89%845K

---89K

-Change in other current liabilities

9.02%-111K

-101.89%-107K

-25.08%-394K

9.62%-94K

-43.68%-125K

-28.42%-122K

-82.76%-53K

-1,557.89%-315K

-89.09%-104K

-611.76%-87K

-Change in other working capital

---42K

--850K

----

Cash from discontinued investing activities

Operating cash flow

9.78%-8.17M

29.14%-7.05M

-0.42%-33.24M

-16.00%-7.45M

20.39%-6.79M

13.40%-9.06M

-29.24%-9.95M

5.34%-33.1M

28.02%-6.42M

9.57%-8.53M

Investing cash flow

Cash flow from continuing investing activities

-27,816.67%-1.68M

-103.45%-361K

99.47%-56K

Net PPE purchase and sale

----

--0

----

-1,183.33%-77K

--0

---3K

Net intangibles purchase and sale

----

--0

----

---1.6M

---361K

---53K

Cash from discontinued investing activities

Investing cash flow

----

--0

----

-27,816.67%-1.68M

-103.45%-361K

99.47%-56K

Financing cash flow

Cash flow from continuing financing activities

274.56%12.57M

-34.78%12.27M

47.65%34.23M

550.18%10.65M

-86.11%1.41M

3.42%3.36M

130.81%18.81M

-47.24%23.18M

-47.52%1.64M

3,022.15%10.15M

Net issuance payments of debt

-64.91%-94K

22.38%-222K

-102.58%-100K

-377.78%-50K

-92.50%293K

-107.79%-57K

63.43%-286K

-57.20%3.88M

-96.94%18K

667.88%3.91M

Net common stock issuance

715.71%12.67M

-30.09%12.49M

56.88%32.1M

320.52%11.25M

-77.03%1.43M

-36.72%1.55M

96.10%17.87M

-39.06%20.46M

-17.15%2.68M

701.80%6.22M

Net preferred stock issuance

----

--611K

--0

----

--0

Proceeds from stock option exercised by employees

----

--1.24M

--1K

--0

----

--0

Net other financing activities

----

132.87%380K

47.54%-554K

-1,838.89%-313K

-75.00%15K

792.13%1.23M

-58.14%-1.16M

-51.72%-1.06M

-93.59%18K

Cash from discontinued financing activities

Financing cash flow

274.56%12.57M

-34.78%12.27M

47.65%34.23M

550.18%10.65M

-86.11%1.41M

3.42%3.36M

130.81%18.81M

-47.24%23.18M

-47.52%1.64M

2,620.38%10.15M

Net cash flow

Beginning cash position

-18.77%11.67M

18.28%6.47M

-67.93%5.47M

-69.45%3.23M

-4.29%8.63M

-17.70%14.37M

-67.93%5.47M

110.77%17.05M

-14.66%10.56M

-71.75%9.01M

Current changes in cash

177.00%4.39M

-41.11%5.22M

108.49%985K

162.16%3.2M

-444.49%-5.38M

32.71%-5.7M

1,848.57%8.87M

-229.43%-11.6M

-210.05%-5.15M

108.00%1.56M

Effect of exchange rate changes

75.61%-10K

-159.38%-19K

-6.25%15K

-18.52%44K

-33.33%-20K

-251.85%-41K

164.00%32K

--16K

--54K

---15K

End cash Position

86.03%16.05M

-18.77%11.67M

18.28%6.47M

-69.45%3.23M

-4.29%8.63M

-17.70%14.37M

-67.93%5.47M

-14.66%10.56M

Free cash flow

9.61%-8.19M

29.14%-7.05M

4.42%-33.24M

-9.83%-7.45M

20.91%-6.79M

22.70%-9.06M

-29.24%-9.95M

0.56%-34.78M

23.97%-6.78M

8.98%-8.59M

Currency Unit

USD

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	9.78%-8.17M	29.14%-7.05M	-0.42%-33.24M	-16.00%-7.45M	20.39%-6.79M	13.40%-9.06M	-29.24%-9.95M	5.34%-33.1M	28.02%-6.42M	9.57%-8.53M
Net income from continuing operations	19.71%-9.72M	27.54%-9.15M	14.68%-41.87M	-2.63%-9.15M	36.66%-7.99M	-28.95%-12.11M	30.47%-12.63M	6.70%-49.08M	37.76%-8.91M	-3.42%-12.61M
Operating gains losses	400.00%30K	-4,064.52%-1.23M	-266.71%-3.65M	1,000.00%9K	-369,300.00%-3.69M	100.96%6K	-98.90%31K	-10.22%2.19M	---1K	--1K
Depreciation and amortization	-9.98%559K	10.71%610K	4.19%2.39M	-1.83%591K	6.47%625K	-4.17%621K	21.10%551K	26.42%2.29M	25.94%602K	24.10%587K
Other non cash items	-99.71%9K	-81.00%274K	6.33%13.38M	-45.31%1.72M	124.06%7.09M	10.36%3.13M	-58.12%1.44M	142.55%12.58M	103.90%3.14M	159.69%3.16M
Change In working capital	37.91%-1.24M	14.53%-153K	-150.65%-11.1M	-43.51%-3.33M	-2,221.58%-5.6M	53.86%-2M	-107.28%-179K	-295.32%-4.43M	-220.59%-2.32M	63.54%-241K
-Change in receivables	411.61%349K	-54.85%465K	170.78%298K	-1,145.16%-324K	28.16%-296K	-168.71%-112K	607.39%1.03M	-117.43%-421K	-49.18%31K	-120.92%-412K
-Change in inventory	-227.62%-536K	110.18%169K	-1.93%-2.17M	-91.49%-810K	-179.86%-115K	122.50%420K	-7,645.45%-1.66M	-0.28%-2.12M	-9.30%-423K	112.96%144K
-Change in prepaid assets	57.86%-1.53M	-610.00%-1.14M	-221.22%-5.01M	-668.81%-2.39M	2,079.66%1.17M	-113.79%-3.63M	-131.56%-160K	-95.98%-1.56M	-154.28%-311K	44.34%-59K
-Change in payables and accrued expense	-56.48%628K	-265.54%-1.13M	-802.95%-3.81M	112.22%288K	-2,475.19%-6.22M	207.68%1.44M	-68.54%682K	-83.02%542K	-208.32%-2.36M	118.32%262K
-Change in other current assets	-50.00%1K	4,183.33%735K	96.91%-17K	-99.64%3K	95.51%-4K	100.15%2K	-260.00%-18K	-34.80%-550K	289.89%845K	---89K
-Change in other current liabilities	9.02%-111K	-101.89%-107K	-25.08%-394K	9.62%-94K	-43.68%-125K	-28.42%-122K	-82.76%-53K	-1,557.89%-315K	-89.09%-104K	-611.76%-87K
-Change in other working capital	---42K	--850K	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	9.78%-8.17M	29.14%-7.05M	-0.42%-33.24M	-16.00%-7.45M	20.39%-6.79M	13.40%-9.06M	-29.24%-9.95M	5.34%-33.1M	28.02%-6.42M	9.57%-8.53M
Investing cash flow
Cash flow from continuing investing activities			0	0	0			-27,816.67%-1.68M	-103.45%-361K	99.47%-56K
Net PPE purchase and sale	----	----	--0	--0	--0	----	----	-1,183.33%-77K	--0	---3K
Net intangibles purchase and sale	----	----	--0	--0	----	----	----	---1.6M	---361K	---53K
Cash from discontinued investing activities
Investing cash flow	----	----	--0	--0	--0	----	----	-27,816.67%-1.68M	-103.45%-361K	99.47%-56K
Financing cash flow
Cash flow from continuing financing activities	274.56%12.57M	-34.78%12.27M	47.65%34.23M	550.18%10.65M	-86.11%1.41M	3.42%3.36M	130.81%18.81M	-47.24%23.18M	-47.52%1.64M	3,022.15%10.15M
Net issuance payments of debt	-64.91%-94K	22.38%-222K	-102.58%-100K	-377.78%-50K	-92.50%293K	-107.79%-57K	63.43%-286K	-57.20%3.88M	-96.94%18K	667.88%3.91M
Net common stock issuance	715.71%12.67M	-30.09%12.49M	56.88%32.1M	320.52%11.25M	-77.03%1.43M	-36.72%1.55M	96.10%17.87M	-39.06%20.46M	-17.15%2.68M	701.80%6.22M
Net preferred stock issuance	----	----	--611K	--0	--0	----	----	--0	--0	--0
Proceeds from stock option exercised by employees	----	----	--1.24M	--1K	--0	----	----	--0	--0	--0
Net other financing activities	----	----	132.87%380K	47.54%-554K	-1,838.89%-313K	-75.00%15K	792.13%1.23M	-58.14%-1.16M	-51.72%-1.06M	-93.59%18K
Cash from discontinued financing activities
Financing cash flow	274.56%12.57M	-34.78%12.27M	47.65%34.23M	550.18%10.65M	-86.11%1.41M	3.42%3.36M	130.81%18.81M	-47.24%23.18M	-47.52%1.64M	2,620.38%10.15M
Net cash flow
Beginning cash position	-18.77%11.67M	18.28%6.47M	-67.93%5.47M	-69.45%3.23M	-4.29%8.63M	-17.70%14.37M	-67.93%5.47M	110.77%17.05M	-14.66%10.56M	-71.75%9.01M
Current changes in cash	177.00%4.39M	-41.11%5.22M	108.49%985K	162.16%3.2M	-444.49%-5.38M	32.71%-5.7M	1,848.57%8.87M	-229.43%-11.6M	-210.05%-5.15M	108.00%1.56M
Effect of exchange rate changes	75.61%-10K	-159.38%-19K	-6.25%15K	-18.52%44K	-33.33%-20K	-251.85%-41K	164.00%32K	--16K	--54K	---15K
End cash Position	86.03%16.05M	-18.77%11.67M	18.28%6.47M	18.28%6.47M	-69.45%3.23M	-4.29%8.63M	-17.70%14.37M	-67.93%5.47M	-67.93%5.47M	-14.66%10.56M
Free cash flow	9.61%-8.19M	29.14%-7.05M	4.42%-33.24M	-9.83%-7.45M	20.91%-6.79M	22.70%-9.06M	-29.24%-9.95M	0.56%-34.78M	23.97%-6.78M	8.98%-8.59M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data